Evaluation of DigniCap™ system for the prevention of chemotherapy-induced hair loss in breast cancer patient

被引：3
|
作者：
Kato, M. [1 ]
Sakuyama, A. [1 ]
Imai, R. [1 ]
Kobayashi, T. [2 ]
机构：
[1] Kato Breast Surg Clin, Kusatsu, Shiga, Japan
[2] Saiseikai Shiga Hosp, Shiga, Japan
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
10.1016/S0960-9776(11)70266-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] ORAL ONDANSETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS IN BREAST-CANCER PATIENTS
    CLAVEL, M
    BONNETERRE, J
    DALLENS, H
    PAILLARSE, JM
    BONSROSSET
    BREMOND
    CAILLERES
    CHOLLET
    CORETTE
    DREYFUS
    DUTIN
    FROGER
    GOUDIER
    GUIOCHET
    KOHN
    LAPLAIGE
    LEBOURGEOIS
    LEJEUNE
    LEROL
    MANDET
    MARTY
    MAYLEVIN
    MELLE
    MIGNOT
    MORVAN
    OBERLING
    OLIVIER
    PATRICOT
    POUILLART
    PREVOT
    PUJADELAURAINE
    RENAUD
    RIMAILHO
    ROMIEU
    CELIGNY, S
    SUZANNE
    VEYRET
    ZYLBERBERG
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (01) : 15 - 19
  • [32] Patient satisfaction with scalp cooling for prevention of chemotherapy-induced alopecia in breast cancer patients: results from EVAScalp
    Koch, J.
    Bitto, F. -F.
    Koenig, A.
    Phan-Brehm, T.
    Vallbracht, T.
    Schinkoethe, T.
    Wolfgarten, M.
    Mahner, S.
    Harbeck, N.
    Wuerstlein, R.
    BREAST, 2019, 44 : S140 - S140
  • [33] Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study
    J. Gavila
    M. Á. Seguí
    L. Calvo
    T. López
    J. J. Alonso
    M. Farto
    R. Sánchez-de la Rosa
    Clinical and Translational Oncology, 2017, 19 : 91 - 104
  • [34] Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study
    Gavila, J.
    Segui, M. A.
    Calvo, L.
    Lopez, T.
    Alonso, J. J.
    Farto, M.
    Sanchez-de la Rosa, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 91 - 104
  • [35] Evaluation of the Effect of HESA-A on the Prevention and Treatment of Chemotherapy-induced Nausea and Vomiting in Breast Cancer and Lung Cancer Patients
    Choliche, Fateme Salehi
    Altememy, Dhiya
    Khosravian, Pegah
    Tehrani, Afsaneh Malekpour
    Ghahe, Maryam Saeedi
    Fekri, Kiavash
    Masumi, Ruholah
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 : 334 - 341
  • [36] Is there a risk of chemotherapy-induced teratogenicity in breast cancer?
    Juarez, A.
    Rivera, A. M.
    Islas, L. P.
    Duran, M. A.
    Tellez, S. E.
    Cruz, J.
    Alarcon, I.
    CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2013, 40 (02): : 55 - 57
  • [37] Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
    Fan, C.
    Foster, B. K.
    Wallace, W. H.
    Xian, C. J.
    CURRENT MOLECULAR MEDICINE, 2011, 11 (02) : 140 - 151
  • [38] Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
    Hausberg, Martin
    Felten, Helmut
    Pfeffer, Stefan
    CASE REPORTS IN ONCOLOGY, 2019, 12 (01): : 1 - 6
  • [39] Management of chemotherapy-induced thromboembolism in breast cancer
    Gbolahan, Olumide B.
    Stankowski-Drengler, Trista J.
    Ibraheem, Abiola
    Engel, Jessica M.
    Onitilo, Adedayo A.
    BREAST CANCER MANAGEMENT, 2015, 4 (04) : 187 - 198
  • [40] Chemotherapy-induced cardiotoxicity in breast cancer patients
    Ibraheem, Abiola
    Stankowski-Drengler, Trista J.
    Gbolahan, Olumide B.
    Engel, Jessica M.
    Onitilo, Adedayo A.
    BREAST CANCER MANAGEMENT, 2016, 5 (01) : 31 - 41
12345